nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—pineal body—multiple sclerosis	0.0436	0.179	CbGeAlD
Cysteamine—SST—peripheral nervous system—multiple sclerosis	0.0406	0.167	CbGeAlD
Cysteamine—SST—nerve—multiple sclerosis	0.0317	0.13	CbGeAlD
Cysteamine—NPY2R—nervous system—multiple sclerosis	0.0182	0.075	CbGeAlD
Cysteamine—NPY2R—central nervous system—multiple sclerosis	0.0176	0.0722	CbGeAlD
Cysteamine—NPY2R—brain—multiple sclerosis	0.0139	0.0573	CbGeAlD
Cysteamine—SST—brainstem—multiple sclerosis	0.0136	0.0559	CbGeAlD
Cysteamine—SST—medulla oblongata—multiple sclerosis	0.00948	0.039	CbGeAlD
Cysteamine—SST—midbrain—multiple sclerosis	0.00866	0.0356	CbGeAlD
Cysteamine—SST—spinal cord—multiple sclerosis	0.00845	0.0348	CbGeAlD
Cysteamine—SST—nervous system—multiple sclerosis	0.00712	0.0293	CbGeAlD
Cysteamine—SST—central nervous system—multiple sclerosis	0.00685	0.0282	CbGeAlD
Cysteamine—SST—cerebellum—multiple sclerosis	0.0067	0.0276	CbGeAlD
Cysteamine—SST—brain—multiple sclerosis	0.00544	0.0224	CbGeAlD
Cysteamine—MPO—spinal cord—multiple sclerosis	0.0034	0.014	CbGeAlD
Cysteamine—MPO—nervous system—multiple sclerosis	0.00287	0.0118	CbGeAlD
Cysteamine—MPO—central nervous system—multiple sclerosis	0.00276	0.0114	CbGeAlD
Cysteamine—MPO—brain—multiple sclerosis	0.00219	0.00902	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00202	0.00514	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00202	0.00513	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00201	0.00512	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GPR65—multiple sclerosis	0.00201	0.00512	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00198	0.00503	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00196	0.00499	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00194	0.00493	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00193	0.00491	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL13—multiple sclerosis	0.00192	0.00489	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR1—multiple sclerosis	0.00192	0.00489	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00189	0.0048	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00187	0.00476	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL13—multiple sclerosis	0.00184	0.00469	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR1—multiple sclerosis	0.00184	0.00469	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00182	0.00463	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00181	0.0046	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.0018	0.00457	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—CCL2—multiple sclerosis	0.00176	0.00448	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00173	0.00441	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00173	0.0044	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00172	0.00439	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.0017	0.00432	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00168	0.00427	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00167	0.00425	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00166	0.00423	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00166	0.00422	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00163	0.00414	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00163	0.00414	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.00162	0.00412	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0016	0.00408	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TYK2—multiple sclerosis	0.0016	0.00407	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00156	0.00397	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00156	0.00397	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL4—multiple sclerosis	0.00156	0.00397	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.00152	0.00387	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.0015	0.00382	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.0015	0.00381	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IFNG—multiple sclerosis	0.0015	0.00381	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00147	0.00375	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00146	0.00372	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—CD4—multiple sclerosis	0.00145	0.00368	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00144	0.00366	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—FAS—multiple sclerosis	0.00142	0.00361	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00141	0.00359	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCL5—multiple sclerosis	0.0014	0.00357	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL3—multiple sclerosis	0.00137	0.00348	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.00136	0.00346	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00135	0.00344	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—S1PR1—multiple sclerosis	0.00134	0.0034	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—multiple sclerosis	0.00134	0.0034	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL2—multiple sclerosis	0.00133	0.00338	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTGER4—multiple sclerosis	0.00132	0.00335	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00132	0.00335	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL3—multiple sclerosis	0.00131	0.00334	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.0013	0.0033	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—S1PR1—multiple sclerosis	0.00128	0.00326	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCR3—multiple sclerosis	0.00127	0.00324	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.00127	0.00323	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTGER4—multiple sclerosis	0.00126	0.00321	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00126	0.00321	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—RGS1—multiple sclerosis	0.00125	0.00319	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR2—multiple sclerosis	0.00124	0.00315	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ICAM1—multiple sclerosis	0.00124	0.00315	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00122	0.00311	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCR3—multiple sclerosis	0.00122	0.0031	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—RGS1—multiple sclerosis	0.0012	0.00305	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00119	0.00304	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GPR65—multiple sclerosis	0.00119	0.00302	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR2—multiple sclerosis	0.00119	0.00302	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00117	0.00298	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00117	0.00298	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00116	0.00296	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.00116	0.00295	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00115	0.00291	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CNR1—multiple sclerosis	0.00114	0.00291	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GPR65—multiple sclerosis	0.00114	0.0029	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RGS1—multiple sclerosis	0.00114	0.00289	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—STAT3—multiple sclerosis	0.00112	0.00285	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00112	0.00284	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—CCL2—multiple sclerosis	0.00111	0.00282	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CNR1—multiple sclerosis	0.0011	0.00279	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RGS1—multiple sclerosis	0.00109	0.00277	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00109	0.00276	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR1—multiple sclerosis	0.00109	0.00276	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GPR65—multiple sclerosis	0.00108	0.00274	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00106	0.0027	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00105	0.00267	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LINGO1—multiple sclerosis	0.00104	0.00265	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR1—multiple sclerosis	0.00104	0.00265	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00104	0.00265	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GPR65—multiple sclerosis	0.00103	0.00263	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.00103	0.00263	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ALB—multiple sclerosis	0.00103	0.00263	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—POMC—multiple sclerosis	0.00103	0.00262	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL10—multiple sclerosis	0.00103	0.00262	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.001	0.00256	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LINGO1—multiple sclerosis	0.001	0.00254	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—POMC—multiple sclerosis	0.000988	0.00251	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL10—multiple sclerosis	0.000986	0.00251	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR1—multiple sclerosis	0.000986	0.00251	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL13—multiple sclerosis	0.000986	0.00251	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000984	0.0025	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—multiple sclerosis	0.000969	0.00246	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR1—multiple sclerosis	0.000945	0.0024	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL13—multiple sclerosis	0.000945	0.0024	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IFNG—multiple sclerosis	0.000942	0.0024	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TAGAP—multiple sclerosis	0.000904	0.0023	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL5—multiple sclerosis	0.000886	0.00225	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.00088	0.00224	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TAGAP—multiple sclerosis	0.000867	0.0022	CbGpPWpGaD
Cysteamine—Mood swings—Betamethasone—multiple sclerosis	0.000866	0.00238	CcSEcCtD
Cysteamine—Mood swings—Dexamethasone—multiple sclerosis	0.000866	0.00238	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000862	0.00237	CcSEcCtD
Cysteamine—Fatigue—Cladribine—multiple sclerosis	0.000861	0.00237	CcSEcCtD
Cysteamine—Constipation—Cladribine—multiple sclerosis	0.000854	0.00235	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CCL5—multiple sclerosis	0.000849	0.00216	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000841	0.00231	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL1B—multiple sclerosis	0.00084	0.00214	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL2—multiple sclerosis	0.000837	0.00213	CbGpPWpGaD
Cysteamine—Discomfort—Azathioprine—multiple sclerosis	0.000837	0.0023	CcSEcCtD
Cysteamine—Feeling abnormal—Cladribine—multiple sclerosis	0.000823	0.00226	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—multiple sclerosis	0.00082	0.00209	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000819	0.00208	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000816	0.00224	CcSEcCtD
Cysteamine—Lethargy—Prednisone—multiple sclerosis	0.000812	0.00223	CcSEcCtD
Cysteamine—Erythema—Mitoxantrone—multiple sclerosis	0.000804	0.00221	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000801	0.00204	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR5—multiple sclerosis	0.000798	0.00203	CbGpPWpGaD
Cysteamine—Urticaria—Cladribine—multiple sclerosis	0.000793	0.00218	CcSEcCtD
Cysteamine—SST—Signaling Pathways—S1PR1—multiple sclerosis	0.00079	0.00201	CbGpPWpGaD
Cysteamine—Body temperature increased—Cladribine—multiple sclerosis	0.000789	0.00217	CcSEcCtD
Cysteamine—Abdominal pain—Cladribine—multiple sclerosis	0.000789	0.00217	CcSEcCtD
Cysteamine—Skin disorder—Azathioprine—multiple sclerosis	0.000789	0.00217	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000785	0.002	CbGpPWpGaD
Cysteamine—Affect lability—Prednisone—multiple sclerosis	0.000784	0.00215	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL6—multiple sclerosis	0.000782	0.00199	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00077	0.00196	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GPC5—multiple sclerosis	0.000769	0.00196	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000768	0.00195	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR5—multiple sclerosis	0.000765	0.00195	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—S1PR1—multiple sclerosis	0.000758	0.00193	CbGpPWpGaD
Cysteamine—Mood swings—Prednisone—multiple sclerosis	0.000754	0.00207	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CD4—multiple sclerosis	0.00075	0.00191	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.00075	0.00191	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000749	0.0019	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000745	0.00189	CbGpPWpGaD
Cysteamine—Anaemia—Mitoxantrone—multiple sclerosis	0.000743	0.00204	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GPC5—multiple sclerosis	0.000737	0.00187	CbGpPWpGaD
Cysteamine—Hypersensitivity—Cladribine—multiple sclerosis	0.000736	0.00202	CcSEcCtD
Cysteamine—Leukopenia—Mitoxantrone—multiple sclerosis	0.00072	0.00198	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000719	0.00183	CbGpPWpGaD
Cysteamine—Asthenia—Cladribine—multiple sclerosis	0.000716	0.00197	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000714	0.00182	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL3—multiple sclerosis	0.000703	0.00179	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000701	0.00193	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCR2—multiple sclerosis	0.0007	0.00178	CbGpPWpGaD
Cysteamine—Convulsion—Mitoxantrone—multiple sclerosis	0.000697	0.00192	CcSEcCtD
Cysteamine—Hypertension—Mitoxantrone—multiple sclerosis	0.000694	0.00191	CcSEcCtD
Cysteamine—Hallucination—Methylprednisolone—multiple sclerosis	0.000692	0.0019	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00069	0.00175	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000683	0.00188	CcSEcCtD
Cysteamine—Diarrhoea—Cladribine—multiple sclerosis	0.000683	0.00188	CcSEcCtD
Cysteamine—Lethargy—Methotrexate—multiple sclerosis	0.000679	0.00187	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PTGER4—multiple sclerosis	0.000676	0.00172	CbGpPWpGaD
Cysteamine—Discomfort—Mitoxantrone—multiple sclerosis	0.000676	0.00186	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCL3—multiple sclerosis	0.000674	0.00171	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RGS1—multiple sclerosis	0.000672	0.00171	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR2—multiple sclerosis	0.000671	0.00171	CbGpPWpGaD
Cysteamine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000669	0.00184	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000668	0.0017	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000664	0.00182	CcSEcCtD
Cysteamine—Confusional state—Mitoxantrone—multiple sclerosis	0.000662	0.00182	CcSEcCtD
Cysteamine—Dizziness—Cladribine—multiple sclerosis	0.00066	0.00181	CcSEcCtD
Cysteamine—Erythema—Prednisolone—multiple sclerosis	0.00066	0.00181	CcSEcCtD
Cysteamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000656	0.0018	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCR3—multiple sclerosis	0.000653	0.00166	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTGER4—multiple sclerosis	0.000648	0.00165	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CNR1—multiple sclerosis	0.000646	0.00164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RGS1—multiple sclerosis	0.000644	0.00164	CbGpPWpGaD
Cysteamine—Abdominal pain—Azathioprine—multiple sclerosis	0.000642	0.00176	CcSEcCtD
Cysteamine—Body temperature increased—Azathioprine—multiple sclerosis	0.000642	0.00176	CcSEcCtD
Cysteamine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000637	0.00175	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GPR65—multiple sclerosis	0.000637	0.00162	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR2—multiple sclerosis	0.000635	0.00162	CbGpPWpGaD
Cysteamine—Vomiting—Cladribine—multiple sclerosis	0.000635	0.00174	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—multiple sclerosis	0.00063	0.00173	CcSEcCtD
Cysteamine—Rash—Cladribine—multiple sclerosis	0.00063	0.00173	CcSEcCtD
Cysteamine—Hallucination—Betamethasone—multiple sclerosis	0.000629	0.00173	CcSEcCtD
Cysteamine—Hallucination—Dexamethasone—multiple sclerosis	0.000629	0.00173	CcSEcCtD
Cysteamine—Dermatitis—Cladribine—multiple sclerosis	0.000629	0.00173	CcSEcCtD
Cysteamine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000628	0.00173	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCR3—multiple sclerosis	0.000626	0.00159	CbGpPWpGaD
Cysteamine—Anorexia—Mitoxantrone—multiple sclerosis	0.000626	0.00172	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—multiple sclerosis	0.000626	0.00172	CcSEcCtD
Cysteamine—Headache—Cladribine—multiple sclerosis	0.000625	0.00172	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—POMC—multiple sclerosis	0.000624	0.00159	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000621	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CNR1—multiple sclerosis	0.000619	0.00157	CbGpPWpGaD
Cysteamine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000614	0.00169	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GPR65—multiple sclerosis	0.000611	0.00155	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL2—multiple sclerosis	0.00061	0.00155	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—multiple sclerosis	0.00061	0.00155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR2—multiple sclerosis	0.000609	0.00155	CbGpPWpGaD
Cysteamine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000609	0.00167	CcSEcCtD
Cysteamine—Erythema—Triamcinolone—multiple sclerosis	0.000607	0.00167	CcSEcCtD
Cysteamine—Erythema—Methylprednisolone—multiple sclerosis	0.000605	0.00166	CcSEcCtD
Cysteamine—Malnutrition—Methylprednisolone—multiple sclerosis	0.000605	0.00166	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.000605	0.00154	CbGpPWpGaD
Cysteamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000598	0.00164	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—POMC—multiple sclerosis	0.000598	0.00152	CbGpPWpGaD
Cysteamine—Nausea—Cladribine—multiple sclerosis	0.000593	0.00163	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CNR1—multiple sclerosis	0.000586	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL2—multiple sclerosis	0.000585	0.00149	CbGpPWpGaD
Cysteamine—Somnolence—Mitoxantrone—multiple sclerosis	0.000583	0.0016	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR1—multiple sclerosis	0.000583	0.00148	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL13—multiple sclerosis	0.000583	0.00148	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000581	0.00148	CbGpPWpGaD
Cysteamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000578	0.00159	CcSEcCtD
Cysteamine—Convulsion—Prednisolone—multiple sclerosis	0.000572	0.00157	CcSEcCtD
Cysteamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00057	0.00157	CcSEcCtD
Cysteamine—Hypertension—Prednisolone—multiple sclerosis	0.00057	0.00157	CcSEcCtD
Cysteamine—Fatigue—Mitoxantrone—multiple sclerosis	0.000566	0.00156	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CNR1—multiple sclerosis	0.000562	0.00143	CbGpPWpGaD
Cysteamine—Constipation—Mitoxantrone—multiple sclerosis	0.000561	0.00154	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCL13—multiple sclerosis	0.000559	0.00142	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR1—multiple sclerosis	0.000559	0.00142	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000557	0.00142	CbGpPWpGaD
Cysteamine—Diarrhoea—Azathioprine—multiple sclerosis	0.000555	0.00153	CcSEcCtD
Cysteamine—Discomfort—Prednisolone—multiple sclerosis	0.000555	0.00153	CcSEcCtD
Cysteamine—Erythema—Betamethasone—multiple sclerosis	0.00055	0.00151	CcSEcCtD
Cysteamine—Erythema—Dexamethasone—multiple sclerosis	0.00055	0.00151	CcSEcCtD
Cysteamine—Hallucination—Prednisone—multiple sclerosis	0.000548	0.00151	CcSEcCtD
Cysteamine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000541	0.00149	CcSEcCtD
Cysteamine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000541	0.00149	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—multiple sclerosis	0.00054	0.00137	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000538	0.00148	CcSEcCtD
Cysteamine—Dizziness—Azathioprine—multiple sclerosis	0.000537	0.00148	CcSEcCtD
Cysteamine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000537	0.00148	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL10—multiple sclerosis	0.000528	0.00134	CbGpPWpGaD
Cysteamine—Convulsion—Triamcinolone—multiple sclerosis	0.000526	0.00144	CcSEcCtD
Cysteamine—Convulsion—Methylprednisolone—multiple sclerosis	0.000524	0.00144	CcSEcCtD
Cysteamine—Hypertension—Triamcinolone—multiple sclerosis	0.000524	0.00144	CcSEcCtD
Cysteamine—Hypertension—Methylprednisolone—multiple sclerosis	0.000523	0.00144	CcSEcCtD
Cysteamine—Urticaria—Mitoxantrone—multiple sclerosis	0.000521	0.00143	CcSEcCtD
Cysteamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000519	0.00143	CcSEcCtD
Cysteamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000519	0.00143	CcSEcCtD
Cysteamine—Vomiting—Azathioprine—multiple sclerosis	0.000516	0.00142	CcSEcCtD
Cysteamine—Rash—Azathioprine—multiple sclerosis	0.000512	0.00141	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000512	0.00141	CcSEcCtD
Cysteamine—Dermatitis—Azathioprine—multiple sclerosis	0.000511	0.00141	CcSEcCtD
Cysteamine—Discomfort—Triamcinolone—multiple sclerosis	0.00051	0.0014	CcSEcCtD
Cysteamine—Discomfort—Methylprednisolone—multiple sclerosis	0.000509	0.0014	CcSEcCtD
Cysteamine—Headache—Azathioprine—multiple sclerosis	0.000509	0.0014	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL10—multiple sclerosis	0.000506	0.00129	CbGpPWpGaD
Cysteamine—Renal failure—Methotrexate—multiple sclerosis	0.000504	0.00139	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCL5—multiple sclerosis	0.000501	0.00127	CbGpPWpGaD
Cysteamine—Confusional state—Methylprednisolone—multiple sclerosis	0.000498	0.00137	CcSEcCtD
Cysteamine—Immune system disorder—Prednisone—multiple sclerosis	0.000497	0.00137	CcSEcCtD
Cysteamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000495	0.00136	CcSEcCtD
Cysteamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000494	0.00136	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—multiple sclerosis	0.000492	0.00125	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—multiple sclerosis	0.000486	0.00124	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000484	0.00133	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000484	0.00123	CbGpPWpGaD
Cysteamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000484	0.00133	CcSEcCtD
Cysteamine—Mental disorder—Prednisone—multiple sclerosis	0.000482	0.00133	CcSEcCtD
Cysteamine—Nausea—Azathioprine—multiple sclerosis	0.000482	0.00133	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CCL5—multiple sclerosis	0.00048	0.00122	CbGpPWpGaD
Cysteamine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00048	0.00132	CcSEcCtD
Cysteamine—Erythema—Prednisone—multiple sclerosis	0.000479	0.00132	CcSEcCtD
Cysteamine—Malnutrition—Prednisone—multiple sclerosis	0.000479	0.00132	CcSEcCtD
Cysteamine—Convulsion—Dexamethasone—multiple sclerosis	0.000477	0.00131	CcSEcCtD
Cysteamine—Convulsion—Betamethasone—multiple sclerosis	0.000477	0.00131	CcSEcCtD
Cysteamine—Hypertension—Dexamethasone—multiple sclerosis	0.000475	0.00131	CcSEcCtD
Cysteamine—Hypertension—Betamethasone—multiple sclerosis	0.000475	0.00131	CcSEcCtD
Cysteamine—Asthenia—Mitoxantrone—multiple sclerosis	0.000471	0.00129	CcSEcCtD
Cysteamine—Discomfort—Betamethasone—multiple sclerosis	0.000463	0.00127	CcSEcCtD
Cysteamine—Discomfort—Dexamethasone—multiple sclerosis	0.000463	0.00127	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCL5—multiple sclerosis	0.000455	0.00116	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000455	0.00125	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—multiple sclerosis	0.000451	0.00124	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCR5—multiple sclerosis	0.000451	0.00115	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000449	0.00123	CcSEcCtD
Cysteamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000449	0.00123	CcSEcCtD
Cysteamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000449	0.00123	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000444	0.00113	CbGpPWpGaD
Cysteamine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000444	0.00122	CcSEcCtD
Cysteamine—Anaemia—Prednisone—multiple sclerosis	0.000443	0.00122	CcSEcCtD
Cysteamine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000441	0.00121	CcSEcCtD
Cysteamine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000441	0.00121	CcSEcCtD
Cysteamine—Agitation—Prednisone—multiple sclerosis	0.000441	0.00121	CcSEcCtD
Cysteamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000436	0.0012	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCL5—multiple sclerosis	0.000436	0.00111	CbGpPWpGaD
Cysteamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000435	0.0012	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—multiple sclerosis	0.000432	0.0011	CbGpPWpGaD
Cysteamine—Anorexia—Dexamethasone—multiple sclerosis	0.000428	0.00118	CcSEcCtD
Cysteamine—Anorexia—Betamethasone—multiple sclerosis	0.000428	0.00118	CcSEcCtD
Cysteamine—Urticaria—Prednisolone—multiple sclerosis	0.000428	0.00118	CcSEcCtD
Cysteamine—Fatigue—Triamcinolone—multiple sclerosis	0.000427	0.00117	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000426	0.00108	CbGpPWpGaD
Cysteamine—Fatigue—Methylprednisolone—multiple sclerosis	0.000426	0.00117	CcSEcCtD
Cysteamine—Vomiting—Mitoxantrone—multiple sclerosis	0.000417	0.00115	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—multiple sclerosis	0.000416	0.00114	CcSEcCtD
Cysteamine—Convulsion—Prednisone—multiple sclerosis	0.000415	0.00114	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL3—multiple sclerosis	0.000415	0.00106	CbGpPWpGaD
Cysteamine—Hypertension—Prednisone—multiple sclerosis	0.000414	0.00114	CcSEcCtD
Cysteamine—Rash—Mitoxantrone—multiple sclerosis	0.000414	0.00114	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000413	0.00114	CcSEcCtD
Cysteamine—Headache—Mitoxantrone—multiple sclerosis	0.000411	0.00113	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCR5—multiple sclerosis	0.000409	0.00104	CbGpPWpGaD
Cysteamine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000408	0.00112	CcSEcCtD
Cysteamine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000407	0.00112	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000405	0.00111	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000404	0.00111	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2RA—multiple sclerosis	0.000404	0.00103	CbGpPWpGaD
Cysteamine—Discomfort—Prednisone—multiple sclerosis	0.000403	0.00111	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—multiple sclerosis	0.000403	0.00111	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—multiple sclerosis	0.000401	0.0011	CcSEcCtD
Cysteamine—Erythema—Methotrexate—multiple sclerosis	0.000401	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTGER4—multiple sclerosis	0.0004	0.00102	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL3—multiple sclerosis	0.000398	0.00101	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000397	0.00109	CcSEcCtD
Cysteamine—Dyspepsia—Betamethasone—multiple sclerosis	0.000395	0.00109	CcSEcCtD
Cysteamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000395	0.00109	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PGR—multiple sclerosis	0.000394	0.001	CbGpPWpGaD
Cysteamine—Urticaria—Triamcinolone—multiple sclerosis	0.000393	0.00108	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—multiple sclerosis	0.000393	0.000999	CbGpPWpGaD
Cysteamine—Urticaria—Methylprednisolone—multiple sclerosis	0.000392	0.00108	CcSEcCtD
Cysteamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000391	0.00108	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000391	0.00108	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000391	0.000995	CbGpPWpGaD
Cysteamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000391	0.00107	CcSEcCtD
Cysteamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000391	0.00107	CcSEcCtD
Cysteamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000391	0.00107	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—multiple sclerosis	0.00039	0.00107	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000388	0.00107	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000388	0.00107	CcSEcCtD
Cysteamine—Fatigue—Betamethasone—multiple sclerosis	0.000387	0.00106	CcSEcCtD
Cysteamine—Fatigue—Dexamethasone—multiple sclerosis	0.000387	0.00106	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2RA—multiple sclerosis	0.000387	0.000984	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR3—multiple sclerosis	0.000386	0.000982	CbGpPWpGaD
Cysteamine—Nervous system disorder—Prednisone—multiple sclerosis	0.000384	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTGER4—multiple sclerosis	0.000383	0.000974	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CD28—multiple sclerosis	0.000382	0.000972	CbGpPWpGaD
Cysteamine—Skin disorder—Prednisone—multiple sclerosis	0.00038	0.00104	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PGR—multiple sclerosis	0.000377	0.00096	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR2—multiple sclerosis	0.000375	0.000955	CbGpPWpGaD
Cysteamine—Anorexia—Prednisone—multiple sclerosis	0.000373	0.00103	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—multiple sclerosis	0.00037	0.00102	CcSEcCtD
Cysteamine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00037	0.00102	CcSEcCtD
Cysteamine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00037	0.00102	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCR3—multiple sclerosis	0.00037	0.000941	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000367	0.00101	CcSEcCtD
Cysteamine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000367	0.00101	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CD28—multiple sclerosis	0.000367	0.000932	CbGpPWpGaD
Cysteamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000365	0.001	CcSEcCtD
Cysteamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000364	0.001	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR2—multiple sclerosis	0.00036	0.000915	CbGpPWpGaD
Cysteamine—Leukopenia—Methotrexate—multiple sclerosis	0.000359	0.000986	CcSEcCtD
Cysteamine—Urticaria—Dexamethasone—multiple sclerosis	0.000357	0.000981	CcSEcCtD
Cysteamine—Urticaria—Betamethasone—multiple sclerosis	0.000357	0.000981	CcSEcCtD
Cysteamine—Dizziness—Prednisolone—multiple sclerosis	0.000356	0.000979	CcSEcCtD
Cysteamine—Asthenia—Triamcinolone—multiple sclerosis	0.000355	0.000976	CcSEcCtD
Cysteamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000355	0.000976	CcSEcCtD
Cysteamine—Abdominal pain—Betamethasone—multiple sclerosis	0.000355	0.000976	CcSEcCtD
Cysteamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000355	0.000976	CcSEcCtD
Cysteamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000355	0.000976	CcSEcCtD
Cysteamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000354	0.000974	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—POMC—multiple sclerosis	0.000352	0.000896	CbGpPWpGaD
Cysteamine—Convulsion—Methotrexate—multiple sclerosis	0.000347	0.000954	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CNR1—multiple sclerosis	0.000346	0.000881	CbGpPWpGaD
Cysteamine—Dyspepsia—Prednisone—multiple sclerosis	0.000344	0.000947	CcSEcCtD
Cysteamine—Decreased appetite—Prednisone—multiple sclerosis	0.00034	0.000935	CcSEcCtD
Cysteamine—Rash—Prednisolone—multiple sclerosis	0.000339	0.000933	CcSEcCtD
Cysteamine—Dermatitis—Prednisolone—multiple sclerosis	0.000339	0.000932	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000339	0.000931	CcSEcCtD
Cysteamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000338	0.000929	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—POMC—multiple sclerosis	0.000338	0.000859	CbGpPWpGaD
Cysteamine—Fatigue—Prednisone—multiple sclerosis	0.000337	0.000927	CcSEcCtD
Cysteamine—Headache—Prednisolone—multiple sclerosis	0.000337	0.000927	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—multiple sclerosis	0.000337	0.000926	CcSEcCtD
Cysteamine—Constipation—Prednisone—multiple sclerosis	0.000335	0.00092	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CNR1—multiple sclerosis	0.000332	0.000845	CbGpPWpGaD
Cysteamine—Confusional state—Methotrexate—multiple sclerosis	0.00033	0.000906	CcSEcCtD
Cysteamine—Dizziness—Triamcinolone—multiple sclerosis	0.000327	0.0009	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000327	0.000899	CcSEcCtD
Cysteamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000327	0.000898	CcSEcCtD
Cysteamine—Feeling abnormal—Prednisone—multiple sclerosis	0.000322	0.000886	CcSEcCtD
Cysteamine—Asthenia—Betamethasone—multiple sclerosis	0.000322	0.000886	CcSEcCtD
Cysteamine—Asthenia—Dexamethasone—multiple sclerosis	0.000322	0.000886	CcSEcCtD
Cysteamine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000321	0.000881	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—POMC—multiple sclerosis	0.00032	0.000814	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00032	0.000879	CcSEcCtD
Cysteamine—Nausea—Prednisolone—multiple sclerosis	0.00032	0.000879	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—multiple sclerosis	0.000318	0.000873	CcSEcCtD
Cysteamine—Vomiting—Triamcinolone—multiple sclerosis	0.000315	0.000865	CcSEcCtD
Cysteamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000314	0.000863	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCL2—multiple sclerosis	0.000313	0.000797	CbGpPWpGaD
Cysteamine—Rash—Triamcinolone—multiple sclerosis	0.000312	0.000858	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCL10—multiple sclerosis	0.000312	0.000793	CbGpPWpGaD
Cysteamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000312	0.000857	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—multiple sclerosis	0.000312	0.000857	CcSEcCtD
Cysteamine—Rash—Methylprednisolone—multiple sclerosis	0.000311	0.000856	CcSEcCtD
Cysteamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000311	0.000855	CcSEcCtD
Cysteamine—Urticaria—Prednisone—multiple sclerosis	0.000311	0.000854	CcSEcCtD
Cysteamine—Headache—Triamcinolone—multiple sclerosis	0.00031	0.000853	CcSEcCtD
Cysteamine—Headache—Methylprednisolone—multiple sclerosis	0.000309	0.000851	CcSEcCtD
Cysteamine—Abdominal pain—Prednisone—multiple sclerosis	0.000309	0.00085	CcSEcCtD
Cysteamine—Body temperature increased—Prednisone—multiple sclerosis	0.000309	0.00085	CcSEcCtD
Cysteamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000307	0.000845	CcSEcCtD
Cysteamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000307	0.000845	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—POMC—multiple sclerosis	0.000307	0.000781	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—multiple sclerosis	0.0003	0.000764	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL10—multiple sclerosis	0.000299	0.000761	CbGpPWpGaD
Cysteamine—Dizziness—Dexamethasone—multiple sclerosis	0.000297	0.000817	CcSEcCtD
Cysteamine—Dizziness—Betamethasone—multiple sclerosis	0.000297	0.000817	CcSEcCtD
Cysteamine—Nausea—Triamcinolone—multiple sclerosis	0.000294	0.000808	CcSEcCtD
Cysteamine—Nausea—Methylprednisolone—multiple sclerosis	0.000293	0.000807	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—multiple sclerosis	0.000291	0.000799	CcSEcCtD
Cysteamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000288	0.000792	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000288	0.000791	CcSEcCtD
Cysteamine—Vomiting—Dexamethasone—multiple sclerosis	0.000286	0.000785	CcSEcCtD
Cysteamine—Vomiting—Betamethasone—multiple sclerosis	0.000286	0.000785	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—TYK2—multiple sclerosis	0.000284	0.000723	CbGpPWpGaD
Cysteamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000284	0.000781	CcSEcCtD
Cysteamine—Rash—Dexamethasone—multiple sclerosis	0.000283	0.000779	CcSEcCtD
Cysteamine—Rash—Betamethasone—multiple sclerosis	0.000283	0.000779	CcSEcCtD
Cysteamine—Dermatitis—Betamethasone—multiple sclerosis	0.000283	0.000778	CcSEcCtD
Cysteamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000283	0.000778	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000282	0.000776	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—multiple sclerosis	0.000282	0.000775	CcSEcCtD
Cysteamine—Headache—Dexamethasone—multiple sclerosis	0.000281	0.000774	CcSEcCtD
Cysteamine—Headache—Betamethasone—multiple sclerosis	0.000281	0.000774	CcSEcCtD
Cysteamine—Asthenia—Prednisone—multiple sclerosis	0.000281	0.000772	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CD86—multiple sclerosis	0.000273	0.000694	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—TYK2—multiple sclerosis	0.000273	0.000693	CbGpPWpGaD
Cysteamine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000269	0.000741	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL5—multiple sclerosis	0.000269	0.000683	CbGpPWpGaD
Cysteamine—Diarrhoea—Prednisone—multiple sclerosis	0.000268	0.000736	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000267	0.000735	CcSEcCtD
Cysteamine—Nausea—Betamethasone—multiple sclerosis	0.000267	0.000734	CcSEcCtD
Cysteamine—Nausea—Dexamethasone—multiple sclerosis	0.000267	0.000734	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CD86—multiple sclerosis	0.000262	0.000665	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—multiple sclerosis	0.000261	0.000663	CbGpPWpGaD
Cysteamine—Urticaria—Methotrexate—multiple sclerosis	0.00026	0.000714	CcSEcCtD
Cysteamine—Dizziness—Prednisone—multiple sclerosis	0.000259	0.000711	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000258	0.00071	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—multiple sclerosis	0.000258	0.00071	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCL5—multiple sclerosis	0.000257	0.000655	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—multiple sclerosis	0.00025	0.000635	CbGpPWpGaD
Cysteamine—Vomiting—Prednisone—multiple sclerosis	0.000249	0.000684	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SPP1—multiple sclerosis	0.000249	0.000633	CbGpPWpGaD
Cysteamine—Rash—Prednisone—multiple sclerosis	0.000247	0.000678	CcSEcCtD
Cysteamine—Dermatitis—Prednisone—multiple sclerosis	0.000246	0.000677	CcSEcCtD
Cysteamine—Headache—Prednisone—multiple sclerosis	0.000245	0.000674	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR5—multiple sclerosis	0.000242	0.000615	CbGpPWpGaD
Cysteamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000241	0.000662	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SPP1—multiple sclerosis	0.000238	0.000606	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2RA—multiple sclerosis	0.000238	0.000606	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—multiple sclerosis	0.000237	0.000602	CbGpPWpGaD
Cysteamine—Asthenia—Methotrexate—multiple sclerosis	0.000235	0.000645	CcSEcCtD
Cysteamine—Nausea—Prednisone—multiple sclerosis	0.000232	0.000639	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR5—multiple sclerosis	0.000232	0.00059	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2RA—multiple sclerosis	0.000229	0.000581	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2—multiple sclerosis	0.000227	0.000577	CbGpPWpGaD
Cysteamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000224	0.000615	CcSEcCtD
Cysteamine—SST—Signaling Pathways—APOE—multiple sclerosis	0.00022	0.00056	CbGpPWpGaD
Cysteamine—Dizziness—Methotrexate—multiple sclerosis	0.000216	0.000594	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APOE—multiple sclerosis	0.000211	0.000537	CbGpPWpGaD
Cysteamine—Vomiting—Methotrexate—multiple sclerosis	0.000208	0.000571	CcSEcCtD
Cysteamine—Rash—Methotrexate—multiple sclerosis	0.000206	0.000567	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—multiple sclerosis	0.000206	0.000566	CcSEcCtD
Cysteamine—Headache—Methotrexate—multiple sclerosis	0.000205	0.000563	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CD80—multiple sclerosis	0.000199	0.000506	CbGpPWpGaD
Cysteamine—Nausea—Methotrexate—multiple sclerosis	0.000194	0.000534	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CD80—multiple sclerosis	0.000191	0.000485	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—POMC—multiple sclerosis	0.000189	0.000481	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—multiple sclerosis	0.000185	0.000471	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—POMC—multiple sclerosis	0.000181	0.000461	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK1—multiple sclerosis	0.000181	0.00046	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL2—multiple sclerosis	0.000177	0.000451	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK1—multiple sclerosis	0.000174	0.000441	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TYK2—multiple sclerosis	0.000168	0.000427	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TYK2—multiple sclerosis	0.000161	0.00041	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—multiple sclerosis	0.00014	0.000356	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—multiple sclerosis	0.000139	0.000354	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—multiple sclerosis	0.000134	0.000341	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—multiple sclerosis	0.000133	0.000339	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—multiple sclerosis	0.000132	0.000336	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—multiple sclerosis	0.000127	0.000323	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—multiple sclerosis	0.000118	0.000299	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—multiple sclerosis	0.000113	0.000287	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—multiple sclerosis	0.000109	0.000278	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—multiple sclerosis	0.000109	0.000277	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK1—multiple sclerosis	0.000107	0.000272	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—multiple sclerosis	0.000105	0.000267	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—multiple sclerosis	0.000105	0.000266	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK1—multiple sclerosis	0.000103	0.000261	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—multiple sclerosis	8.22e-05	0.000209	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—multiple sclerosis	7.88e-05	0.0002	CbGpPWpGaD
